{"meta":{"query_hash":"34309b9b0a13","filters":{"venue":"Immunotherapy Open Access"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/34309b9b0a13","api":"https://metacan.xera.ac/api/v1/cohort?venue=Immunotherapy+Open+Access"},"results":[{"id":"W2525561336","doi":"","title":"Oncolytic HSV-1 with enhancement of both oncolysis and safety","year":2016,"lang":"en","type":"article","venue":"Immunotherapy Open Access","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncolytic virus; Virotherapy; Virus; Immune system; Cancer research; Biology; Virology; Immunology","score_opus":0.028243479027759085,"score_gpt":0.3767506293745042,"score_spread":0.3485071503467451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525561336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9134022,0.026790462,0.041960273,0.0007040022,0.0002542734,0.00022409263,0.0007066383,0.00055120577,0.015406952],"genre_scores_gemma":[0.9756486,0.0051693716,0.013140798,0.00013158267,0.000054432323,0.00006240696,0.00040313395,0.000048283266,0.0053414437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998437,0.00002025073,0.000010418528,0.00002776089,0.000055608132,0.000042244646],"domain_scores_gemma":[0.99991775,0.000011068114,0.000028345805,0.000009657557,0.00001825774,0.000014870586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001823546,0.00057526876,0.0002738561,0.00036152595,0.0001521061,0.00046293135,0.00020829856,0.00042379848,0.001194549],"category_scores_gemma":[0.00016780195,0.00012337857,0.00032461807,0.0002999882,0.00026133604,0.0004078252,0.0003039403,0.0006065666,0.00039760958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009837211,0.000052006126,0.00013310787,0.00010557291,0.000006987522,0.000039339553,0.000014467357,0.00016453832,0.9887165,0.00078992674,0.00013228795,0.009746961],"study_design_scores_gemma":[0.000011025371,0.00027658013,0.00055802084,0.000006515456,0.000019305118,0.00028718286,0.000008601927,0.0006545637,0.99337536,0.000135231,0.0046621207,0.000005597103],"about_ca_topic_score_codex":0.0006149503,"about_ca_topic_score_gemma":0.0007001714,"teacher_disagreement_score":0.001194549,"about_ca_system_score_codex":0.00046419931,"about_ca_system_score_gemma":0.00047121276,"threshold_uncertainty_score":0.003996134},"labels":[],"label_agreement":null}]}